The era of the new directly acting antivirals: Has the time come for kidney transplant only in compensated cirrhosis?

E-ISSN： 1432-2277|28|5|620-621

ISSN： 0934-0874

Source： TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol.28, Iss.5, 2015-05, pp. : 620-621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct‐acting anti‐virals

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 866-876

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐Effectiveness of New Direct‐Acting Antivirals to Prevent Post–Liver Transplant Recurrent Hepatitis

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 7, 2015-07 ,pp. : 1817-1826

John Wiley & Sons Inc

Access to resources Recommend Favorite

HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct‐acting antivirals

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 1, 2018-01 ,pp. : 72-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Voluntarism and Pancreatic Societies: Fuelling a New Trend for Which the Time Has Come?

Pancreatology, Vol. 9, Iss. 4, 2009-05 ,pp. : III-IV

Karger

Access to resources Recommend Favorite

NAOMI—Her Time Has Come

By Schechter M.T.

Journal of Urban Health: Bulletin of the New York Academy of Medicine, Vol. 79, Iss. 2, 2002-06 ,pp. : 164-165

Springer Publishing Company

Access to resources Recommend Favorite